All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.

MLA

Sogni, Philippe, et al. “All-Oral Direct-Acting Antiviral Regimens in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis Are Efficient and Safe: Real-Life Results From the Prospective ANRS CO13-HEPAVIH Cohort.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 63, no. 6, Sept. 2016, pp. 763–70. EBSCOhost, https://doi.org/10.1093/cid/ciw379.

APA

Sogni, P., Gilbert, C., Lacombe, K., Piroth, L., Rosenthal, E., Miailhes, P., Gervais, A., Esterle, L., Chas, J., Poizot-Martin, I., Dominguez, S., Simon, A., Morlat, P., Neau, D., Zucman, D., Bouchaud, O., Lascoux-Combe, C., Bani-Sadr, F., Alric, L., … Wittkop, L. (2016). All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 63(6), 763–770. https://doi.org/10.1093/cid/ciw379

Chicago

Sogni, Philippe, Camille Gilbert, Karine Lacombe, Lionel Piroth, Eric Rosenthal, Patrick Miailhes, Anne Gervais, et al. 2016. “All-Oral Direct-Acting Antiviral Regimens in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis Are Efficient and Safe: Real-Life Results From the Prospective ANRS CO13-HEPAVIH Cohort.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 63 (6): 763–70. doi:10.1093/cid/ciw379.